During the last session, QuidelOrtho Corporation (NASDAQ:QDEL)’s traded shares were 4.28 million, with the beta value of the company hitting 0.06. At the end of the trading day, the stock’s price was $25.85, reflecting an intraday loss of -0.35% or -$0.09. The 52-week high for the QDEL share is $49.45, that puts it down -91.3 from that peak though still a striking 8.05% gain since the share price plummeted to a 52-week low of $23.77. The company’s market capitalization is $1.74B, and the average trade volume was 1.19 million shares over the past three months.
QuidelOrtho Corporation (QDEL) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.10. QDEL has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.11.
QuidelOrtho Corporation (NASDAQ:QDEL) trade information
QuidelOrtho Corporation (QDEL) registered a -0.35% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -0.35% in intraday trading to $25.85, hitting a weekly high. The stock’s 5-day price performance is -6.98%, and it has moved by -8.85% in 30 days. Based on these gigs, the overall price performance for the year is -39.18%.
The consensus price target of analysts on Wall Street is $110, which implies an increase of 76.5% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $50 and $125 respectively. As a result, QDEL is trading at a discount of -383.56% off the target high and -93.42% off the low.
QuidelOrtho Corporation (QDEL) estimates and forecasts
In the rating firms’ projections, revenue will decrease -2.81% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 622.32M as predicted by 8 analyst(s). Meanwhile, a consensus of 8 analyst(s) estimates revenue growth to 683.77M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 637M and 727.1M respectively. In this case, analysts expect current quarter sales to shrink by -2.31% and then drop by -5.96% in the coming quarter.
While earnings are projected to return 26.15% in 2025, the next five years will return 32.82% per annum.
QDEL Dividends
QuidelOrtho Corporation is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 9.49 million shares, is of T. ROWE PRICE INVESTMENT MANAGEMENT, INC.’s that is approximately 14.1502% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $315.42 million.
Also, the Mutual Funds coming in first place with the largest holdings of QuidelOrtho Corporation (QDEL) shares are iShares Trust-iShares Core S&P Small-Cap ETF and T. Rowe Price Mid-Cap Growth Fund, Inc. . Data provided on Mar 31, 2025 indicates that iShares Trust-iShares Core S&P Small-Cap ETF owns about 4.08 shares. This amounts to just over 6.04 percent of the company’s overall shares, with a $105.35 million market value. The same data shows that the other fund manager holds slightly less at 3.27, or about 4.84% of the stock, which is worth about $84.41 million.
